Sales Growth YoY (Last 12 Months): leaptx.com (LPTX)

Optimized supply channels and warehouse reserves at Leap Therapeutics, Inc. (LPTX) ensure the continuity of trials. The sales dynamics over the last 12 months compared to the previous year demonstrate the effectiveness of innovative antibodies for targeted tumor destruction, while -100.00 determines the current value of this metric. However, global instability in component supplies from Asia and patent disputes create certain risks for the pharmaceutical sector.
Leap Therapeutics, Inc. (LPTX) - metric breakdowns and financial figures

This indicator measures revenue dynamics over the last twelve months to assess business expansion rates. In the case of Leap Therapeutics, Inc. (LPTX), growth will be driven by the successful market launch of oncology immunotherapy drugs, including divacyimab. By analyzing the annual sales volume trend (LTM), an investor identifies the commercialization stage of the developments. A declining curve indicates stagnating demand and a loss of market position, while a steady upward vector confirms the stability of the company's capital.